Share Name Share Symbol Market Type Share ISIN Share Description
Faron Pharma LSE:FARN London Ordinary Share FI4000153309 ORD NPV (DI)
  Price Change % Change Share Price Shares Traded Last Trade
  -4.00p -3.43% 112.50p 192,084 15:32:37
Bid Price Offer Price High Price Low Price Open Price
110.00p 115.00p 119.00p 112.50p 116.50p
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 -18.7 -67.5 - 34.91

Faron Pharma (FARN) Latest News

More Faron Pharma News
Faron Pharma Takeover Rumours

Faron Pharma (FARN) Share Charts

1 Year Faron Pharma Chart

1 Year Faron Pharma Chart

1 Month Faron Pharma Chart

1 Month Faron Pharma Chart

Intraday Faron Pharma Chart

Intraday Faron Pharma Chart

Faron Pharma (FARN) Discussions and Chat

Faron Pharma Forums and Chat

Date Time Title Posts
21/5/201818:51Respite for ARDS sufferers430

Add a New Thread

Faron Pharma (FARN) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
2018-05-22 16:06:37112.507,5008,437.50O
2018-05-22 15:30:00113.45352399.34O
2018-05-22 15:28:19113.305,0005,665.00O
2018-05-22 15:27:43113.30436493.99O
2018-05-22 15:27:23110.50641708.31O
View all Faron Pharma trades in real-time

Faron Pharma (FARN) Top Chat Posts

DateSubject
22/5/2018
09:20
Faron Pharma Daily Update: Faron Pharma is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker FARN. The last closing price for Faron Pharma was 116.50p.
Faron Pharma has a 4 week average price of 65p and a 12 week average price of 65p.
The 1 year high share price is 915p while the 1 year low share price is currently 65p.
There are currently 31,027,894 shares in issue and the average daily traded volume is 945,477 shares. The market capitalisation of Faron Pharma is £34,906,380.75.
15/5/2018
10:45
craigo121: 90% drop in share price does not make a bargain! It's dropped 90% for a reason the drug failed they spent 30 million developing not much left in the coffers apart from the 2nd drug 5 million development should equate to 50-60p per share
10/5/2018
15:16
bangers and cash1: Placebo makers, don’t know who to trust some random guy with a short or institutions who decided to buy at many multiples of the share price. Hmmm. Also how can you claim people are ramping when you are flat out lying and posting over and over again, clearly trying to scare people into selling to suit your short. Please leave.
09/5/2018
20:45
deltalo: The bounce has happened but like a bouncing ball the heigh's get lower with each bounce. There is no income to pay for any new trials let alone pay for the rest of the last one. The whole inflation in the share price was on the back of a positive outcome from this trial from the start. What I would like to know is where's the funding coming from and if there is any new trials, how much and how many years will it take. I know something and that's I'm not waiting and I'm not paying. This will fall to its real worth.
03/5/2018
15:35
allonblack: This is so predictable. CEO mouths off in london post period end about trial results on 8 May and then suddenly the share price week before is nothing to see here move along. Buy the dip.
06/4/2018
11:11
paxman: Breq from over at Stocko attended. She said: Some interesting things not obvious from the presentation. Company estimates trial results by May 8. That's the date final 2017 results are announced. Obviously just a target as we all know trial results can be delayed. Mention of further share price gains possible soon. Said in a controlled but positive way. i.e. company still optimistic on trial results. 100,000 treatments available by mid 2019 because company expects demand to be that high. How could doctors not use Traumakine if effective? Breq scanned the Faron website/Linkedin etc. New appointments with a focus on delivering Traumakine so Faron still confident.
19/9/2017
14:37
x54v: The prior move up from February was quite something. Clearly the share price can really motor when it gets going.
13/9/2017
11:47
x54v: Good breakout here today after a multi-month consolidation. One of the directors clearly very keen on the shares buying a £456,750 worth of stock a couple of days ago. Quite a considerable purchase. Https://uk.advfn.com/stock-market/london/faron-pharma-FARN/share-news/Faron-Pharmaceuticals-Oy-Directors-Dealings/75619275
08/5/2017
14:08
jamesd888: Today's RNS were good news and share price drops might be a good opp to buy now.
Faron Pharma share price data is direct from the London Stock Exchange
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:31 V: D:20180523 01:09:55